Researchers in the Department of Molecular Oncology use the latest technologies to rapidly identify genes that are involved in the development of cancer. The proteins produced by these genes may serve as targets for novel chemotherapy drugs and other cancer treatments, or imaging scans. We then use a range of techniques to validate the role of the novel candidate genes in the development of cancer. The ultimate aim is to translate these findings into improved treatment options for cancer patients.
Dr. Samuel Aparicio’s laboratory focuses on the molecular pathways involved in breast cancer development.
Dr. Francois Benard’s team focuses on developing and using imaging techniques to characterise tumours in patients, and in animal models of cancer.
Dr. David Huntsman‘s team applies novel genomics technologies to ovarian cancer.
Dr. Kuo-Shyan Lin’s laboratory is developing radiotracers for applications in oncology and neuroscience.
Dr. Sohrab Shah uses computational approaches to study cancer genomes
Dr. Poul Sorensen’s team studies a range of childhood cancers as well as a subset of breast tumours.
Dr. Kasmintan Schrader’s research involves the molecular diagnosis and characterization of hereditary cancer syndromes in the research and clinical setting with a view to improved surveillance and treatment of associated cancers